SCHEMBL2852858

SCHEMBL2852858

S=[C]c1ncccn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1467021 0.67
SCHEMBL151679 0.67
SCHEMBL195035 0.67
SCHEMBL1324980 0.67
SCHEMBL28061488 0.67 CLK4 (0.38)
SCHEMBL534717 0.67
SCHEMBL1201044 0.67
Hydrochloric Acid SCHEMBL7414247 0.65
SCHEMBL21670004 0.65
SCHEMBL30827004 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0947507-B1 NOVEL TETRAHYDROBENZINDOLONE DERIVATIVES MEIJI SEIKA KAISHA (JP) 2005-02-23 EP claimed
US-6077840-A FOR TREATING OR PREVENTING PROGESTERONE-RELATED DISEASES, FOR HAVING AN ABORTION, OR FOR ORALLY PREVENTING CONCEPTION, BREAST CANCER, OVARIAN CANCER, HYSTEROMYOMA, ENDOMETRIOSIS, MENINGIOMA, MYELOMA, OSTEOPOROSIS MEIJI SEIKA KAISHA, LTD. (JP) 2000-06-20 US claimed
EP-0947507-A1 NOVEL TETRAHYDROBENZINDOLONE DERIVATIVES MEIJI SEIKA KAISHA LTD. (JP) 1999-10-06 EP claimed
US-20100233415-A1 OPTICAL RECORDING MEDIUM AND AZO METAL CHELATE COMPOUND MITSUI CHEMICALS, INC. (JP) 2010-09-16 US disclosed
US-7786079-B2 Substituted nonadepsipeptides AICURIS GMBH & CO. KG. (DE) 2010-08-31 US disclosed
EP-1809653-B1 SUBSTITUTED NONADEPSIPEPTIDES AICURIS GMBH & CO KG (DE) 2010-01-20 EP disclosed
CN-101370875-A Optical recording medium and azo metal chelate compound MITSUI CHEMICALS INC (JP) 2009-02-18 CN disclosed
EP-1997856-A1 OPTICAL RECORDING MEDIUM AND AZO METAL CHELATE COMPOUND Mitsui Chemicals, Inc. (JP) 2008-12-03 EP disclosed
US-20080058251-A1 Substituted nonadepsipeptides BAYER HEALTHCARE AG (DE) 2008-03-06 US disclosed
EP-1809653-A1 SUBSTITUTED NONADEPSIPEPTIDES AiCuris GmbH & Co. KG (DE) 2007-07-25 EP disclosed
US-7202254-B2 Antibacterial compounds: process for their preparation and pharmaceutical compositions containing them DR. REDDY'S LABORATORIES LIMITED (IN) 2007-04-10 US disclosed
WO-2004101531-A1 ANTIINFECTIVE 1,2,3-TRIAZOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM DR. REDDY'S LABORATORIES LTD. (IN) 2004-11-25 WO disclosed
EP-1467977-A1 NOVEL ANTIBACTERIAL COMPOUNDS:PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. Dr. Reddy's Laboratories Ltd. (IN) 2004-10-20 EP disclosed
US-6777410-B2 SUCH AS 9-(2-METHOXYPHENYL)-3-(1-METHYLETHYL)-(1,3)OXAZOLO-(2,3)ISOINDOLE-2,5(3H,9H)-DIONE; DIABETES AND COMPLICATIONS; OBESITY BANYU PHARMACEUTICAL CO., LTD. (JP) 2004-08-17 US disclosed
US-20040053923-A1 Novel isoindole derivatives BANYU PHARMACEUTICAL CO., LTD. 2004-03-18 US disclosed
US-6608098-B1 Diabetes or obesity, 2-(4-(3-isopropyl-2,5-dioxo-2,3-dihydro-1H-pyrrolo(2,1-a) isoindol-9(5H)-yl)phenoxy)-N-propylacetamide BANYU PHARMACEUTICAL CO., LTD. (JP) 2003-08-19 US disclosed
WO-2003059894-A1 NOVEL ANTIBACTERIAL COMPOUNDS:PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. DR.REDDY'S LABORATORIES LTD. (IN) 2003-07-24 WO disclosed
EP-1207161-A1 NOVEL ISOINDOLE DERIVATIVES BANYU PHARMACEUTICAL CO., LTD. (JP) 2002-05-22 EP disclosed
US-6077840-A FOR TREATING OR PREVENTING PROGESTERONE-RELATED DISEASES, FOR HAVING AN ABORTION, OR FOR ORALLY PREVENTING CONCEPTION, BREAST CANCER, OVARIAN CANCER, HYSTEROMYOMA, ENDOMETRIOSIS, MENINGIOMA, MYELOMA, OSTEOPOROSIS MEIJI SEIKA KAISHA, LTD. (JP) 2000-06-20 US disclosed
EP-0947507-A1 NOVEL TETRAHYDROBENZINDOLONE DERIVATIVES MEIJI SEIKA KAISHA LTD. (JP) 1999-10-06 EP disclosed